A palmitoyl-tailed sequential oligopeptide carrier for engineering immunogenic conjugates

Vaccine

Volumn 25, Issue 37-38, 2007, Pages 6708-6712

  Kargakis, Michael ^a   Zevgiti, Stella ^a   Krikorian, Dimitrios ^a   Sakarellos Daitsiotis, Maria ^a   Sakarellos, Constantinos ^a   Panou Pomonis, Eugenia ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Immunogenic conjugates; Palmitoyl immunostimulator; Sequential oligopeptide carriers

Indexed keywords

AUTOANTIGEN; DRUG CARRIER; EPITOPE; FREUND ADJUVANT; OLIGOPEPTIDE; PROLYLPROLYLGLYCYLMETHIONYLARGINYLPROLYLPROLINE; TETRAPEPTIDE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG MECHANISM; DRUG SYNTHESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; NONHUMAN; PRIORITY JOURNAL; RABBIT; SYSTEMIC LUPUS ERYTHEMATOSUS;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES; CELL MEMBRANE PERMEABILITY; HELA CELLS; HUMANS; IMMUNIZATION; IMMUNOCONJUGATES; MOLECULAR SEQUENCE DATA; OLIGOPEPTIDES; PALMITIC ACID; RABBITS;

EID: 34548279887     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.07.007     Document Type: Article

References (24)

1. Kaumaya P.T., Berndt K.D., Heidorn D.B., Trewhella J., Kedzy F.J., and Goldberg E. Synthesis and biophysical characterization of engineered topographic immunogenic determinants with alpha alpha topology. Biochemistry 29 (1990) 13-23
2. Kobs-Conrad S., Lee H., DiGeorge A.M., and Kaumaya P.T. Engineered topographic determinants with alpha beta, beta alpha beta, and beta alpha beta alpha topologies show high affinity binding to native protein antigen (lactate dehydrogenase-C4). J Biol Chem 268 (1993) 25285-25295
3. Chai S.K., Clavijo P., Tam J.P., and Zavala F. Immunogenic properties of multiple antigen peptide system containing defined T and B epitopes. J Immunol 149 (1992) 2385-2390
4. Sadler K., and Tam J.P. Peptide dendrimers: application and synthesis. Rev Mol Biotechnol 90 (2002) 195-229
5. Mezo G., Oliveira E., Krikorian D., Freijlbrief M., Jakob A., Tsikaris V., et al. Synthesis and comparison of antibody recognition of conjugates containing herpes simplex virus type 1 glycoprotein D epitope VII. Bioconjug Chem 14 (2003) 1260-1269
6. Tuchscher G., Mutter M., and Houben Weyl. Template-assembled synthetic proteins. In: Goodman M., Felix A., Moroder L., and Toniolo C. (Eds). Methods of organic chemistry: synthesis of peptides and peptidomimetics vol. E22d (2003), Thieme, Stuttgart 7-67
7. Sundaram R., DaKappagari Nk., and Kaumaya P.T.P. Synthetic peptides as cancer vaccines. Biopolymers (Pept Sci) 66 (2002) 200-216
8. 4 lipopeptide account for its powerful adjuvanticity to HLA class I-restricted CD8+ T-lymphocytes. Eur J Immunol 33 (2003) 2044-2052
9. ε-palmitoyl-lysine moiety increase uptake and maturation of dendritic cells through a Toll-like receptor-2 pathway and trigger a Th1-dependent protective immunity. Eur J Immunol 34 (2004) 3102-3114
10. Sakarellos-Daitsiotis M., Krikorian D., Panou-Pomonis E., and Sakarellos C. Artificial carriers: a strategy for constructing antigenic/immunogenic conjugates. Curr Med Chem 6 (2006) 1715-1735
11. n-II as an innovative and multifunctional approach. Curr Med Chem 12 (2005) 1469-1479
12. n) for multiple anchoring of antigenic/immunogenic peptides. Methods 19 (1999) 133-141
13. Tsikaris V., Sakarellos C., Cung M.T., Marraud M., and Sakarellos-Daitsiotis M. Concept and design of a new class of a sequential oligopeptide carrier (SOC) for covalent attachment of multiple antigenic peptides. Biopolymers 38 (1996) 291-293
14. n, as scaffolds for the reconstitution of antigenic proteins: applications in solid phase immunoassays. J Pharm Biomed Anal 34 (2004) 761-769
15. Krikorian D., Panou-Pomonis E., Voitharou C., Sakarellos C., and Sakarellos-Daitsiotis M. A peptide carrier with a built-in vaccine adjuvant: construction of immunogenic conjugates. Bioconjug Chem 16 (2005) 812-819
16. n-II), influences the antibody recognition: application to the Sm main autoimmune epitope. Biopolymers 54 (2000) 1-20
17. Tsikaris V., Vlachoyiannopoulos P.G., Panou-Pomonis E., Marraud M., Sakarellos C., Moutsopoulos H.M., et al. Immunoreactivity and conformation of the P-P-G-M-R-P-P repetitive epitope of the Sm autoantigen. Int J Pept Protein Res 48 (1996) 319-327
18. Petrovas C.P., Vlachoyiannopoulos P.G., Tzioufas A.G., Alexopoulos Ch., Tsikaris V., Sakarellos-Daitsiotis M., et al. A major Sm epitope anchored to sequential oligopeptide carriers is a suitable antigenic substrate to detect anti-Sm antibodies. J Immunol Methods 220 (1998) 59-68
19. Bodansky M., and Bodansky A. The practice of peptide synthesis. 2nd ed. (1994), Springer, Berlin
20. Houben-Weyl. In: Goodman M., Felix A., Moroder L., and Toniolo G. (Eds). Methods of organic chemistry: synthesis of peptide and peptidomimetics. 4th ed. E22 (2003), Thieme, Stuttgard a-e
21. n) as mimic of the Sm autoantigen: synthesis, conformation and biological assays. J Peptide Sci 7 (2001) 105-114
22. Craft J., and Fatenejad S. Self-antigens and epitope spreading in systemic autoimmunity. Arthritis Rheum 10 (1997) 1374-1382
23. Vlachoyiannopoulos P.G., Petrovas C., Tzioufas A.G., Alexopoulos Ch., Tsikaris V., Guialis A., et al. No evidence of epitope spreading after immunization with the major Sm epitope P-P-G-M-R-P-P anchored to sequential oligopeptide carriers (SOCs). J Autoimmun 14 (2000) 53-61
24. Stephens G., O'Luanaigh N., Reilly D., Harriott P., Walker B., Fitzgerald D., et al. A sequence within the cytoplasmic tail of GpIIb independently activates platelet aggregation and thromboxane synthesis. J Biol Chem 273 (1998) 20317-20322